Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Other financing activities (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Other financing activities data on record, last reported at $5.7 million in Q3 2025.

  • For Q3 2025, Other financing activities rose 945.2% year-over-year to $5.7 million; the TTM value through Dec 2025 reached $5.2 million, changed N/A, while the annual FY2025 figure was $7.7 million, N/A changed from the prior year.
  • Other financing activities reached $5.7 million in Q3 2025 per CAI's latest filing, up from -$1.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $5.7 million in Q3 2025 and bottomed at -$1.0 million in Q4 2024.